BMNR printed two back-to-back positive earnings moves — and short sellers responded by quietly rebuilding, even as the stock held its gains and options traders stayed bullish.
The short position tells a story of cautious re-engagement. Bears had covered hard into the July 17 earnings release, pulling from a peak above 58 million shares to a trough near 45.5 million. Since then, shorts have added back. The position is now 49.1 million shares — 17.2% of the free float — up nearly 8% in a single session on July 21 alone, and up 40% from the level registered a month ago. That monthly rebuild is the most important context here: this is not a residual short book being managed down, but a position that has been actively reconstituted after the earnings print. The ORTEX short score has ticked back to 54.9, sitting roughly in the middle of its recent range and consistent with the early-July tone before the pre-earnings unwind.
The borrow market, however, is not cooperating with the bearish thesis. Availability has tightened from around 460% in mid-June to 200% today — still firmly in comfortable territory, where two shares sit available for every one already borrowed. Cost to borrow has fallen sharply, down 30% on the week to just 0.38%, its lowest level in the past month despite the brief spike above 2.3% in early July. That combination — rising short interest but falling borrow costs and ample availability — says this rebuilding is deliberate and orderly, not a forced or desperate trade. Options traders are still leaning in the same direction as before earnings: the put/call ratio of 0.33 sits just below its 20-day mean of 0.34 and remains well off the 52-week high of 0.90, reinforcing that call demand has dominated options flow through the entire earnings period.
What bulls and bears are debating is the valuation case for a name that has had an extraordinary growth story but questionable financial health. Revenue growth is extreme — one earlier analysis flagged over 300% year-on-year expansion — yet the Piotroski F-Score of 3 and deeply negative free cash flow margins signal that the balance sheet is still catching up. The trailing P/E multiple is running near 20.8x, up modestly on the week and month, suggesting the market is prepared to pay for growth. The earnings history supports that willingness: the two most recent events produced next-day moves of +7.7% (July 17) and +8.1% (July 14), with the five-day drift following the July 14 release reaching nearly 18%. Against that backdrop, the ORTEX short score rank of 21 and a factor-score sector ranking at the 50th percentile suggest the broader quantitative picture is mixed rather than decisively bearish.
Institutional flow adds nuance. Vanguard, BlackRock, Citadel, and ARK all reported net additions in the most recent quarterly filings, with Citadel adding over 5.9 million shares and Susquehanna adding 6.1 million. Geode Capital added 2.4 million shares with a reporting date as recently as June 30. That picture of major institutional buyers absorbing shares while short sellers rebuild is the central tension in the name right now. Peers traded in a mixed direction on the week: BTCS gained 5.9% and MSTR added 4.5%, while BTBT slipped 4.2% — BMNR's 5.8% weekly gain broadly in line with the better-performing end of its cohort rather than a standout outlier.
The next scheduled earnings date is not until November 20, leaving a long runway before the next hard catalyst — making the pace of short-position rebuilding and any shift in borrow conditions the primary data points worth tracking in the weeks ahead.
See the live data behind this article on ORTEX.
Open BMNR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
